NCT02412423View on ClinicalTrials.gov

Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

March 31, 2017

Conditions
Hematopoietic Stem Cell Transplantation
Interventions
DRUG

post-transplantation cyclophosphamide

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT02412423 - Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors | Biotech Hunter | Biotech Hunter